Investor Letters
Letters through October 31, 2025
2 letters reporting on the period ending October 31, 2025, in each firm's own reckoning.
- Invenomic Capital Management Annual Shareholder Report - October 31, 2025 Invenomic Fund attributes the year’s pressure to value’s weakness against growth and an unusually strong momentum factor. The portfolio remained defensively positioned near its lower historical net exposure range as management cited elevated valuations and AI-driven euphoria as asymmetric downside risk. November 1, 2024 to October 31, 2025 —
- Forager Funds Management Monthly Report | October 2025 Forager Australian Shares Fund sold Bravura Solutions after its outlook upgrade drove volatility, judging a material growth uplift necessary to support the valuation. It expects Caterpillar's acquisition of RPMGlobal to close in February and considers the bid fair, while Praemium and Aroa Biosurgery issued encouraging updates and OFX disappointed. October 2025 BVS $947M